Top Stories
Latest Coverage
New Advances in Gaucher Disease Classification: Clinical Characteristics of Type I, Type II, Type III, and Rare Subtypes
Comprehensive overview of Gaucher disease classification, including Type I, Type II, Type III, and rare subtypes with...
Comprehensive overview of Gaucher disease classification, including Type I, Type II, Type III, and rare subtypes with...
Is Helicobacter pylori Infection Guaranteed to Cause Stomach Cancer? Many People Have Misunderstood It
When many people see “Helicobacter pylori positive” on their medical examination report, their first reaction is ofte...
When many people see “Helicobacter pylori positive” on their medical examination report, their first reaction is ofte...
Breast Cancer Screening Guide: What Should Women of Different Ages Do?
Breast cancer has become one of the most common cancers affecting women worldwide. In the past, many people associate...
Breast cancer has become one of the most common cancers affecting women worldwide. In the past, many people associate...
Innovative Drugs Driven by Policy and Clinical Progress
Against the backdrop of a rapidly evolving global pharmaceutical landscape, China’s innovative drugs sector is transi...
Against the backdrop of a rapidly evolving global pharmaceutical landscape, China’s innovative drugs sector is transi...
Recurrent Respiratory Infections with Malnutrition and Growth Delay — Beware of the Rare Pediatric Disease: Cystic Fibrosis (CF)
Some children seem to suffer from chronic respiratory problems that never fully resolve: recurrent pneumonia, persist...
Some children seem to suffer from chronic respiratory problems that never fully resolve: recurrent pneumonia, persist...
China’s First IL-1β Monoclonal Antibody Approved: Firsekibart Brings New Breakthrough to Gout Treatment
Gout, often referred to as the “King of Pain,” has become one of the fastest-growing metabolic diseases in China. Dur...
Gout, often referred to as the “King of Pain,” has become one of the fastest-growing metabolic diseases in China. Dur...
